Targeted Oncology presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
May 9th 2022
Expert hematologist-oncologist Ajay Nooka, MD, MPH, FACP, centers discussion around a clinical case to review updates in the treatment of newly diagnosed multiple myeloma.
April 29th 2022
Expert hematologist-oncologist Rafael Fonseca, MD, reviews the diagnosis and management of an 81-year-old-man who presents with transplant-ineligible multiple myeloma.
April 26th 2022
Expert oncologist Zofia Piotrowska, MD, reviews the case of a 59-year-old woman who is diagnosed and treated for EGFR exon 20–positive non–small cell lung cancer.
April 21st 2022
Expert Joel Neal, MD, PhD, speaks to the management of a 64-year-old man diagnosed with EGFR exon20 insertion–positive NSCLC.
April 20th 2022
John Mascarenhas, MD, reviews the case of a 76-year-old woman with myelofibrosis and her treatment with pacritinib.
April 19th 2022
Srdan Verstovsek, MD, PhD, provides insight on treatment of primary myelofibrosis, including ruxolitinib, and comments on some of the challenges, unmet needs, and future directions in the field.
April 18th 2022
Dr John Allan reviews the case of a 70-year-old woman with newly diagnosed CLL and discusses current treatment strategies and challenges.
April 7th 2022
Pashna Munshi, MD, comments on available treatments for steroid-refractory chronic graft-versus-host disease (cGVHD), including ruxolitinib, and discusses challenges to diagnosis and management of the disease.
March 23rd 2022
Yi-Bin Chen, MD, provides insight on treatment of steroid-refractory chronic GVHD with ruxolitinib.